Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expression
Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expression
复制标题
DOI:
10.1038/sj.cgt.7700782
复制
发表时间:
2005-02
影响因子:
6.4
通讯作者:
H. Fujiwara;T. Kubota;H. Amaike;S. Inada;Kazuhiro Takashima;K. Atsuji;M. Yoshimura;M. Maemondo;K. Narumi;T. Nukiwa;Kunio Matsumoto;Toshikazu Nakamura;A. Hagiwara;H. Yamagishi
中科院分区:
文献类型:
--
作者:
H. Fujiwara;T. Kubota;H. Amaike;S. Inada;Kazuhiro Takashima;K. Atsuji;M. Yoshimura;M. Maemondo;K. Narumi;T. Nukiwa;Kunio Matsumoto;Toshikazu Nakamura;A. Hagiwara;H. Yamagishi
Peritoneal dissemination is the most common mode of metastasis in gastric cancer. We previously reported the importance of milky spots (MS), peritoneal lymphoid tissues, as selective sites of cancer implantation in peritoneal dissemination. In the present study, we first demonstrated that intraperitoneal injection of adenovirus vector encoding the GFP gene into tumor-free nude mice resulted in GFP expression at omental and mesenteric MS; MS macrophages were target cells for adenovirus infection. We confirmed that intraperitoneal injection of adenovirus vector encoding the NK4 gene (AdNK4) resulted in NK4 production localized to the peritoneal cavity, especially the omentum. Adenovirus vector-mediated MS-selective transgene expression was markedly impaired in tumor-bearing mice whose MS had already been replaced by infiltrating cancer cells. However, prior injection of AdNK4 successfully inhibited MS-selective cancer cell implantation, resulting in suppression of peritoneal dissemination and prolongation of survival. Adenovirus vector-mediated MS-selective delivery of a therapeutic gene may prevent peritoneal dissemination of gastric cancer.